Related Experiment Video
Updated: Dec 21, 2025

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
MicroRNA-1324 inhibits cell proliferative ability and invasiveness by targeting MECP2 in gastric cancer
1Department of Gastrointestinal and Colorectal Surgery, China-Japan Union Hospital of Jilin University, Changchun, China. 776726739@qq.com.
Objective:
The aim of this study was to investigate the expression level and potential molecular mechanism of microRNA-1324 in gastric cancer (GCa) to provide a new perspective for the diagnosis and treatment of GCa.
Patients And Methods:
The expression levels of microRNA-1324 and MECP2 in GCa tissues and cell lines were detected using quantitative Real Time Polymerase Chain Reaction (qRT-PCR). The influence of microRNA-1324 and MECP2 on the proliferation or invasiveness of GCa cells were investigated by cell counting kit-8 (CCK-8) and colony formation assay or transwell assay, respectively. Furthermore, the regulatory interplay between microRNA-1324 and MECP2 was verified via Dual-Luciferase reporting assay, qRT-PCR, and Western Blot.
Results:
QRT-PCR results revealed that microRNA-1324 expression was remarkably down-regulated in GCa tissues and cell lines, while the expression of MECP2 was remarkably up-regulated. Subsequently, we confirmed that miR-1324 could target and bind to MECP2, as well as inhibit its expression. Inhibition of microRNA-1324 remarkably enhanced the proliferative capacity and invasiveness of GCa cells. However, opposite results were observed after inhibiting MECP2 expression. At the same time, flow cytometry revealed that inhibition of microRNA-1324 accelerated cell cycle but inhibited apoptosis. Conversely, opposite results were observed when MECP2 was down-regulated in vitro.
Conclusions:
MicroRNA-1324 was remarkably down-regulated in GCa tissues or cell lines. Meanwhile, it could inhibit MECP2 expression, and promote the proliferation and invasion of GCa cells, eventually participating in the occurrence and development of GCa.
Insights
MicroRNA-1324 is down-regulated in gastric cancer (GCa), inhibiting MECP2. Lower microRNA-1324 levels promote GCa cell proliferation and invasion, highlighting its role in GCa development.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Gastric cancer (GCa) remains a significant global health challenge.
- Understanding the molecular mechanisms underlying GCa progression is crucial for developing effective therapies.
Purpose of the Study:
- To investigate the expression of microRNA-1324 in GCa.
- To elucidate the molecular mechanism of microRNA-1324 in GCa development.
- To explore microRNA-1324 as a potential diagnostic and therapeutic target for GCa.
Main Methods:
- Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) to measure microRNA-1324 and MECP2 expression.
- Cell counting kit-8 (CCK-8), colony formation, and Transwell assays to assess cell proliferation and invasion.
- Dual-Luciferase reporter assay, qRT-PCR, and Western Blot to confirm the regulatory interaction between microRNA-1324 and MECP2.
Main Results:
- MicroRNA-1324 was significantly down-regulated in GCa tissues and cell lines.
- MECP2 expression was significantly up-regulated in GCa tissues and cell lines.
- MicroRNA-1324 directly targets and inhibits MECP2 expression.
- Inhibition of microRNA-1324 enhanced GCa cell proliferation and invasion, accelerated cell cycle, and inhibited apoptosis.
- Inhibition of MECP2 yielded opposite effects, suggesting a critical role in GCa progression.
Conclusions:
- MicroRNA-1324 is a tumor suppressor microRNA in gastric cancer.
- The down-regulation of microRNA-1324 contributes to GCa development by up-regulating MECP2.
- MicroRNA-1324 may serve as a potential biomarker and therapeutic target for gastric cancer.
Related Concept Videos
MicroRNAs
MicroRNAs
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Master Transcription Regulators
Induced Pluripotent Stem Cells
Somatic...

